While previous studies have shown that EVs from various cancers modulate the TME by delivering oncogenic proteins and RNA to recipient cells [44, 45], our research uniquely elucidates the specific mechanisms through which CD147-high EVs disrupt the endothelial barrier and facilitate tumor cell dissemination in GC. This evidence concerns the gene BSG and cancer.